Company / Depreciation & Amortization
Corcept Therapeutics Incorporated Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.1M
FY2025
5-year range
$525.0K / $1.1M
FY2021-FY2025
Trend
+44.5%
vs FY2024
Sector context
#120 of 163
Health Care
What the data says
At $1M, Corcept Therapeutics Incorporated's depreciation & amortization ranks #44 of 163 in the Health Care sector. Depreciation & Amortization has fluctuated over the past 10 years, ranging from $87,000 in FY2018 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +37.2%.
Increased from $1M to $1M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +29.8%
- 5-Year CAGR
- +37.2%
- 10-Year CAGR
- -
Sector benchmark
#44 of 163 in Health CareTop 26% of 163This company $1.1M Sector average $219.4M
▼
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +37.2%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 44.5% year-over-year.
- Ranks #120 out of 163 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | +44.5% |
| FY2024 | $795.0K | -23.7% |
| FY2023 | $1.0M | +98.5% |
| FY2022 | $525.0K | -25.3% |
| FY2021 | $703.0K | +197.9% |
| FY2020 | $236.0K | +122.6% |
| FY2019 | $106.0K | +21.8% |
| FY2018 | $87.0K | -17.9% |
| FY2017 | $106.0K | -24.8% |
| FY2016 | $141.0K | -9.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026